The χ2-test was applied to assess the relationship between the expressions of IFITM1 and the clinical and pathologic features of patients with pancreatic cancer, including gender, age at diagnosis, tumor size, histologic differentiation, TNM stage, nodal status, and distant metastasis. This evidence concerns the gene IFITM1 and neoplasm.